YuanDa Pharmaceutical's Executive Director and CEO, Zhou Chao, increased his holdings by 101,000 shares at a price of approximately HKD 3.95 per share

智通財經
2024.04.10 07:39

香港聯交所最新資料顯示，4 月 8 日，遠大醫藥獲執行董事、行政總裁周超增持 10.10 萬股，每股作價 3.9550 港元，總金額為 39.9455 萬港元。增持後最新持股數目 26.30 萬股。

智通財經 APP 獲悉，香港聯交所最新資料顯示，4 月 8 日，遠大醫藥 (00512) 獲執行董事、行政總裁周超增持 10.10 萬股，每股作價 3.9550 港元，總金額為 39.9455 萬港元。增持後最新持股數目 26.30 萬股。

Source: 智通財經 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.